Ovarian Cancer Trial, Recruiting NCT06312124 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06312124
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Part I (Survey/Information stage):

  • People who are 45 years of age or older
  • People who are female or were assigned female at birth
  • People who have a scheduled appointment with a non-gynaecological surgeon

Part II (Procedure stage):

  • People who are 45 years of age or older
  • People who have at least one fallopian tube still in place
  • People who do not want or plan to have children in the future
  • People who are considered to have an average risk of developing ovarian cancer — meaning no known genetic risk factors for ovarian cancer (if a family history suggests a possible hereditary risk but no genetic testing has been done, the trial site would refer that person for genetic evaluation first)
  • People who are already scheduled for a non-gynaecological surgery inside the abdomen or pelvis
  • People considered a suitable candidate by both a gynaecological surgeon and their primary (non-gynaecological) surgeon
  • People who have read, agreed to, and signed the trial consent form

Who may not be able to join:

Part I:

  • People who are not fluent in English or Spanish (note: people who are not fluent in English or Spanish but meet all other criteria may still be eligible to enter Part II directly — confirm with the trial site)
  • People with a known inherited susceptibility to ovarian cancer

Part II:

  • People with a personal history of a gynaecological cancer
  • People who carry a gene variant linked to hereditary breast or ovarian cancer risk (for example, BRCA1, BRCA2, or similar variants)
  • People whose pre-surgery scans showed a suspicious growth on the ovaries, fallopian tubes, or uterus
  • People who have previously had both fallopian tubes removed, or both fallopian tubes and ovaries removed
  • People who have an ESSURE device or any other implanted tubal contraceptive device in place at the time of surgery
  • People who are currently pregnant
  • People whose surgery is an emergency procedure that must be completed within 24 hours, or where their health is in immediate danger
  • People whose primary surgeon expects that adding this procedure would significantly extend the operation time (more than 30–40 minutes)
  • People whose planned surgery position (for example, lying face-down or on their side) would prevent the surgeon from accessing the pelvic area
  • People with a known history of pelvic scarring or significant internal adhesions (bands of scar tissue)
  • People whose planned surgery is intended for comfort or symptom management only (palliative intent), rather than treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kara Long Roche, MD, Memorial Sloan Kettering Cancer Center

Phone: 212-639-7043

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 March 2024
Est. completion
8 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of Opportunistic Salpingectomy/OS after completion of educational module

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov